Seegene Inc
상단으로
Contact Us

Not Available for sale in the United States

  • Conventional
    PCR
  • CE-IVD
    marked

Seeplex®
HPV4A ACE Screening

Simultaneous genotyping of HPV 16, HPV 18 and screening (16 high-risk HPV & HPV 6 / 11)

Seeplex® HPV4A ACE Screening can simultaneously detect genotype (HPV 16 and 18) and screen for 16 high-risk types and vaccine related 2 low-risk types (HPV 6/11) from patients’ cervical brush/swab, or liquid-based cytology specimen. (ex.ThinPrep®, specimen transport medium, etc.) This assay enables multiple detection of infected HPV with single specimen based on DPO™ technology.

Key Features and Benefits

  • Multiplex PCR

    Simultaneous HPV 16,18 genotyping and 16 high-risk HPV and HPV 6/11 screening

  • Useful monitoring

    Useful tool for surveillance and infection control

  • Powerful performance with unique technology

    Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies

  • Informative assay

    Assistant of appropriate treatment and management for co-infection

  • Validated process control

    Accurate system for result interpretation included Internal Control

  • Reduction Contamination risk

    A single round PCR process and 8-MOP reduces the carryover contamination risk

  • Analytes

    Seeplex®
    HPV4A ACE Screening

    • High-risk HPV common[1] (HRC)
    • Human Papillomavirus 16 (HPV 16)
    • Human Papillomavirus 18 (HPV 18)
    • Human Papillomavirus 6/11[2] (HPV 6/11)
    • Internal Control (IC)
  • Specimens

    • Liquid based cytology (e.g., ThinPrep® and Surepath™)
    • Cervical swab
  • Ordering Information

    Product
    Cat No. / Size
    Seeplex® HPV4A ACE Screening
    HP6401Y / 50 rxns

Result

IDResult
1HRC, HPV 6/11
2HRC, HPV 6/11
3HPV-16, HRC
4HRC
5HRC
6HRC
7HRC, HPV 6/11
8HRC, HPV 6/11

1~8: Clinical samples

Note

[1] High-risk HPV common(HRC, 16 types) : 26, 31, 33, 35, 39, 45 ,51, 52, 53, 56, 58, 59, 66, 68, 73, 82 Vaccine related HPV : 6,11,16,18

[2] Vaccine related HPV : 6,11,16,18